whatshot

CLYM   $9.54  7.07% Market Open

Climb Bio, Inc.
show_chart Advanced Chart of CLYM

Current temperature: 22.68
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 12
Target Price Mean 16.25
Mean unverified/preliminary 16.25 / 16.25
Target Price Low / High 8.00 / 26.00
Median / STD DEV 16.00 / 6.09
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy ActivelyBuy
rsi ActivelyBuy Buy None
macd None None None
stoch None None None
ma20 Sell Sell Sell
ma50 None None None
ma100 None Buy ActivelyBuy
Candlestick PatternApril 24, 2026 Long Legged - consists of a Doji with very long upper and lower shadows. Indicates strong forces balanced in opposition.
ISIN US28658R1068
ceo Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Website https://eliemtx.com
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.